“Priority Review” of CBD extract granted by FDA
Epidiolex is a standardized, plant-derived Cannabidiol (CBD) extract formulated by GW Pharmaceuticals, a company that originates in England and also has offices located in California. The US Food and Drug Administration will undertake a “priority review” of data specific to the safety and efficacy of this new drug which...